NAA15

N-alpha-acetyltransferase 15, NatA auxiliary subunit · Q9BXJ9 · NAA15 on Sugi Atlas →

0 patent compounds predicted against NAA15, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to NAA15 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Acelarin First Line Randomised Pancreatic Study PHASE2/PHASE3SUSPENDED
Compared the Efficacy and Safety of CDOP Combined With Chidamide and CDOP in de Novo Peripheral T Cell Lymphoma Patients PHASE3UNKNOWN
Effects of Vitamin B3 in Patients With Ataxia Telangiectasia PHASE2COMPLETED
Metabolic Cofactor Supplementation in Alzheimer's Disease (AD) and Parkinson's Disease (PD) Patients PHASE2COMPLETED
Trial of the Histone-Deacetylase Inhibitor ITF2357 Followed by Mechlorethamine in Relapsed/Refractory Hodgkin's Lymphoma PHASE1/PHASE2COMPLETED
PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS PHASE2COMPLETED
Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome PHASE1COMPLETED
Safety, Tolerability and Pharmacokinetics of Benfo-Oxythiamine (B-OT) in Healthy Volunteers PHASE1COMPLETED
Nucleoside Therapy in Patients With Telomere Biology Disorders PHASE1RECRUITING
Evaluation of the Safety and the Tolerability of a Combination of Two HIV Inducers in Patients With Undetectable Viral Load PHASE1COMPLETED
EXpanding Prenatal Cell Free DNA Screening Across moNogenic Disorders (EXPAND) nanRECRUITING
Biomarker for Creatine Deficiency Syndromes (BioCDS) nanWITHDRAWN
Effect of Adenovirus E1A Oncogene on DNA Replication Dynamics nanUNKNOWN
Pilates Training in Multiple Sclerosis nanCOMPLETED
Thermogenic Silencer Regulatory Factors in Humans nanACTIVE_NOT_RECRUITING
Melatonin in Pregnancy nanCOMPLETED
The Contribution of Optical Mapping to the Characterization of Chromosomal Rearrangements in Patients With Neurodevelopmental Disorders nanRECRUITING
Role of Genetic Factors in the Development of Lung Disease nanRECRUITING
Southeastern ATTR Amyloidosis Consortium: SEATTRAC Family Registry nanNOT_YET_RECRUITING
Diagnosis of RSTS: Identification of the Acetylation Profiles as Epigenetic Markers for Assessing Causality of CREBBP and EP300 Variants. nanUNKNOWN
Preparation of IPSC for Cell Gene Editing for the Treatment of AATD nanENROLLING_BY_INVITATION
Elucidating the Molecular and Biochemical Basis of the Human AhR-mutation Disease nanUNKNOWN
Induced Pluripotent Stem Cells for Niemann Pick Disease nanCOMPLETED
The Predictive Factors of Good Clinical Response to Cholinesterase Inhibitors in Alzheimer Disease and Mixed Dementia nanCOMPLETED
TG Gene Mutations and Congenital Hypothyroidism nanCOMPLETED
Sirtuin1 in COVID19 Patients nanUNKNOWN
Study of Chediak-Higashi Syndrome nanRECRUITING
Rate of Progression of PCDH15-Related Retinal Degeneration in Usher Syndrome 1F nanACTIVE_NOT_RECRUITING
A Study of the Interaction Between Tumor Susceptibility Gene Glycine N-methyltransferase (GNMT) and Lung Cancer nanUNKNOWN
Ataxia-telangiectasia: Treating Mitochondrial Dysfunction With Nicotinamide Riboside nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a NAA15 binder may also engage these)

ProteinNameSimilarity
Q5R4J9 1.000 Q5R4J9 →
Q80UM3 1.000 Q80UM3 →
Q6N069 0.991 Q6N069 →
Q5E993 0.975 Q5E993 →
Q5R882 0.974 Q5R882 →
D2SW95 0.973 D2SW95 →
Q9DBB4 0.972 Q9DBB4 →
Q5R922 0.972 Q5R922 →
Q5ZIA5 0.971 Q5ZIA5 →
COPB1 Coatomer subunit beta 0.971 landscape →
Q6TGY8 0.970 Q6TGY8 →
Q9HBG6 0.970 Q9HBG6 →
Q9SV21 0.970 Q9SV21 →
Q9CRD2 0.970 Q9CRD2 →
Q9SV20 0.969 Q9SV20 →
Q3B8M3 0.969 Q3B8M3 →
Q9JIF7 0.969 Q9JIF7 →
EMC2 ER membrane protein complex subunit 2 0.969 landscape →
Q5R644 0.969 Q5R644 →
EIF3A Eukaryotic translation initiation factor 3 subunit A 0.969 landscape →
P23514 0.969 P23514 →
Q96JC1 0.969 Q96JC1 →
A0JN39 0.969 A0JN39 →
Q66HV4 0.968 Q66HV4 →
Q5ZLA5 0.968 Q5ZLA5 →
A4QNE0 0.968 A4QNE0 →
Q9CZW5 0.968 Q9CZW5 →
B5DGH9 0.968 B5DGH9 →
Q8RWF0 0.967 Q8RWF0 →
A4GWN3 0.967 A4GWN3 →